Kidney Disease Clinical Trials in San Antonio

Showing 321-340 of 340 trials

A Study to Evaluate Chitosan Chewing Gum in Patients With Chronic Kidney Disease

NCT01475760

The purpose of this study is to determine the efficacy of chitosan chewing gum (K2CG) in reducing serum phosphorus in subjects with chronic kidney disease.

Chronic Kidney Disease

Denver Nephrologists, P.C.167 participantsStarted Nov 2011

Tempe, Arizona, United States • Denver, Colorado, United States • Meridian, Idaho, United States +1 more locations

TERMINATEDPhase 2< 1 mile

Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD

NCT00372489

The purpose of this study was to evaluate the long term safety and tolerability of peginesatide for the maintenance of hemoglobin in participants with chronic kidney disease (CKD) who had received at least 24 weeks of peginesatide treatment in an earlier study.

Chronic Renal FailureChronic Kidney DiseaseAnemia

Affymax81 participantsStarted Sep 2006

Pine Bluff, Arkansas, United States • Mountain View, California, United States • Lauderdale Lakes, Florida, United States +6 more locations

A Study to Evaluate Chitosan Chewing Gum in Patients With Chronic Kidney Disease

Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD

Kidney Disease Trials in Other Cities

Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose Vitamin D

Safety and Tolerability Study of TAK-165 in Subjects With Tumors Expressing HER2

A Study to Compare Early Steroid Withdrawal and Long-Term Steroid Maintenance Therapy in Kidney Transplant Patients

Study to Investigate the Effects of AZD6140 in Patients With Renal Impairment and in Healthy Volunteers

Optimizing Prograf® Therapy in Renal Transplant Patients

Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly)

Evaluate the Survival Benefits of Zemplar Versus Calcijex in Subjects w/ Stage V Chronic Kidney Disease on Hemodialysis

A Comparison Of Study Drug Blood Levels After One Dose Of GSK189075 In Subjects With Normal And Reduced Kidney Function

Survival Study Of Oncophage® vs. Observation In Patients With Kidney Cancer

A Study of the Safety and Tolerance of Regadenoson in Subjects With Renal Impairment

A Dose Escalation and Safety Study of I5NP to Prevent Acute Kidney Injury (AKI) in Patients at High Risk of AKI Undergoing Major Cardiovascular Surgery (QRK.004)

A Study to Evaluate the Safety and Efficacy of Paricalcitol Capsules in Reducing Serum Intact Parathyroid Hormone Levels in End Stage Renal Disease Subjects on Peritoneal Dialysis

A Multi-Centered, Two-Arm, Randomized Study Comparing the Effects of AAT-023 (Zuragen) Solution, and Heparin on the Incidence of Catheter Related Blood Stream Infections in Tunneled Chronic Central Venous Catheters for Dialysis

YSPSL for Prevention of Delayed Graft Function Part B

Treatment Use Study With Sunitinib (SU011248) For Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma

Combination of Capecitabine and GTI-2040 in the Treatment of Renal Cell Carcinoma

Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.

A Study to Evaluate the Pharmacokinetics of VI-0521 Subjects With Renal Impairment

Other Conditions in San Antonio